Occidental Petroleum Corp [NYSE: OXY] price plunged by -1.11 percent to reach at -$0.56. The one-year OXY stock forecast points to a potential upside of 18.21. The average equity rating for OXY stock is currently 2.55, trading closer to a bullish pattern in the stock
Occidental Petroleum Corp [NYSE: OXY] traded at a high on Tuesday, posting a 1.62 gain after which it closed the day’ session at $48.84. The results of the trading session contributed to over 15069653 shares changing hands. Over the past one week, the price volatility
Occidental Petroleum Corp [NYSE: OXY] traded at a high on Monday, posting a 3.42 gain after which it closed the day’ session at $48.38. The results of the trading session contributed to over 11039560 shares changing hands. Over the past one week, the price volatility
Occidental Petroleum Corp [NYSE: OXY] slipped around -2.27 points on Monday, while shares priced at $46.65 at the close of the session, down -4.64%. Compared to the average trading volume of 11.31M shares, OXY reached a trading volume of 18057478 in the most recent trading
Occidental Petroleum Corp [NYSE: OXY] surged by $0.27 during the normal trading session on while it closed the day at $49.56. Occidental Petroleum Corp stock has also loss -4.64% of its value over the past 7 days. However, OXY stock has declined by -3.43% in
Occidental Petroleum Corp [NYSE: OXY] plunged by -$1.42 during the normal trading session on while it closed the day at $50.55. Occidental Petroleum Corp stock has also loss -4.04% of its value over the past 7 days. However, OXY stock has declined by -2.26% in
Occidental Petroleum Corp [NYSE: OXY] surged by $1.38 during the normal trading session on while it closed the day at $52.68. Occidental Petroleum Corp stock has also gained 4.30% of its value over the past 7 days. However, OXY stock has declined by -3.46% in
On the back of growing market operation and the results of testing another vaccine, our indexes rose Key-U.S. indices closed in the green zone on Monday, November 23. The market was supported by statements by the British pharmaceutical company AstraZeneca on the potential 90 percent
Copyright © 2024, Powered by Smart TechOne
